Considering 30-days investment horizon, China is expected to generate 38.7 times less return on investment than Integrated. But when comparing it to its historical volatility, China Shenghuo Pharmaceutical Holdings Inc. is 10.03 times less risky than Integrated. It trades about 0.05 of its potential returns per unit of risk. Integrated Biopharma Inc. is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 3.00 in Integrated Biopharma Inc. on April 26, 2012 and sell it today you would earn a total of 4.00 from holding Integrated Biopharma Inc. or generate 133.33% return on investment over 30 days.
Diversification
Good diversification
Overlapping area represents amount of risk that can be diversified away by holding China Shenghuo Pharmaceutical and Integrated Biopharma Inc. in the same portfolio (assuming nothing else is changed)
98% of all equities and portfolios perform better than China Shenghuo Pharmaceutical Holdings Inc.. Compared with the overall equity markets, risk-adjusted returns on investments in China Shenghuo Pharmaceutical Holdings Inc. are ranked lower than 2 (%) of all global equities and portfolios over the last 30 days.
92% of all equities and portfolios perform better than Integrated Biopharma Inc.. Compared with the overall equity markets, risk-adjusted returns on investments in Integrated Biopharma Inc. are ranked lower than 8 (%) of all global equities and portfolios over the last 30 days.
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
